Low density lipoprotein screening: Difference between revisions
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 19: | Line 19: | ||
There is insufficient evidence to recommend for or against screening for [[dyslipidemia]] among infants, children, adolescents, or young adults less than 20 years of age ([[United states preventive services task force recommendations scheme#USPSTF Grade Definitions|Grade: I statement]].<ref> | There is insufficient evidence to recommend for or against screening for [[dyslipidemia]] among infants, children, adolescents, or young adults less than 20 years of age ([[United states preventive services task force recommendations scheme#USPSTF Grade Definitions|Grade: I statement]].<ref> | ||
U.S. Preventive Services Task Force. Screening for Lipid Disorders in Children: Recommendation Statement. July 2007.[http://www.uspreventiveservicestaskforce.org/uspstf07/chlipid/chlipidrs.htm]</ref> | U.S. Preventive Services Task Force. Screening for Lipid Disorders in Children: Recommendation Statement. July 2007.[http://www.uspreventiveservicestaskforce.org/uspstf07/chlipid/chlipidrs.htm]</ref> | ||
===Screening Components=== | |||
Screening for [[high LDL]] includes: | |||
* Identification of risk factors for [[coronary artery disease]] | |||
* Estimation of the 10-year risk of cardiovascular disease | |||
* Measurement of fasting lipid panel (total [[cholesterol]], [[LDL]], [[HDL]], [[triglycerides]]) | |||
==References== | ==References== | ||
Revision as of 03:27, 28 September 2014
|
Low Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Low density lipoprotein screening On the Web |
|
American Roentgen Ray Society Images of Low density lipoprotein screening |
|
Risk calculators and risk factors for Low density lipoprotein screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [5]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [6]
Overview
According to the United States Preventive Services Task Force (USPSTF), screening for high LDL-cholesterol (LDL-c), is indicated among men 35 years and older (Grade: A Recommendation), men age 20 to 35 years in case of an elevated risk for coronary heart disease (Grade: B Recommendation), women age 45 years and older for in case of an elevated risk for coronary heart disease (Grade: A Recommendation), women age 20 to 45 years in case of an elevated risk for coronary heart disease (Grade: B Recommendation).[1] There is insufficient evidence to recommend for or against screening for dyslipidemia among infants, children, adolescents, or young adults less than 20 years of age (Grade: I statement.[2]
Screening
Screening in Adults
Screening for dyslipidemia, including high LDL, depends on the gender, age, and the risk for coronary heart disease. Screening for high HDL is indicated among the following:[3]
- Men 35 years and older (Grade: A Recommendation)
- Men 20 to 35 years in case of an elevated risk for coronary heart disease (Grade: B Recommendation)
- Women 45 years and older for in case of an elevated risk for coronary heart disease (Grade: A Recommendation)
- Women 20 to 45 years in case of an elevated risk for coronary heart disease (Grade: B Recommendation)
Screening in Children
There is insufficient evidence to recommend for or against screening for dyslipidemia among infants, children, adolescents, or young adults less than 20 years of age (Grade: I statement.[4]
Screening Components
Screening for high LDL includes:
- Identification of risk factors for coronary artery disease
- Estimation of the 10-year risk of cardiovascular disease
- Measurement of fasting lipid panel (total cholesterol, LDL, HDL, triglycerides)
References
- ↑ Screening for Lipid Disorders in Adults, Topic Page. U.S. Preventive Services Task Force. [1]
- ↑ U.S. Preventive Services Task Force. Screening for Lipid Disorders in Children: Recommendation Statement. July 2007.[2]
- ↑ Screening for Lipid Disorders in Adults, Topic Page. U.S. Preventive Services Task Force. [3]
- ↑ U.S. Preventive Services Task Force. Screening for Lipid Disorders in Children: Recommendation Statement. July 2007.[4]